Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Lack of muscle mTOR kinase activity causes early onset myopathy and compromises whole-body homeostasis.

Zhang Q, Duplany A, Moncollin V, Mouradian S, Goillot E, Mazelin L, Gauthier K, Streichenberger N, Angleraux C, Chen J, Ding S, Schaeffer L, Gangloff YG.

J Cachexia Sarcopenia Muscle. 2018 Nov 21. doi: 10.1002/jcsm.12336. [Epub ahead of print]

2.

Prestressed cells are prone to cytoskeleton failures under localized shear strain: an experimental demonstration on muscle precursor cells.

Streppa L, Ratti F, Goillot E, Devin A, Schaeffer L, Arneodo A, Argoul F.

Sci Rep. 2018 Jun 5;8(1):8602. doi: 10.1038/s41598-018-26797-4.

3.

Identification of protein features encoded by alternative exons using Exon Ontology.

Tranchevent LC, Aubé F, Dulaurier L, Benoit-Pilven C, Rey A, Poret A, Chautard E, Mortada H, Desmet FO, Chakrama FZ, Moreno-Garcia MA, Goillot E, Janczarski S, Mortreux F, Bourgeois CF, Auboeuf D.

Genome Res. 2017 Jun;27(6):1087-1097. doi: 10.1101/gr.212696.116. Epub 2017 Apr 18.

4.

LSD1 Controls Timely MyoD Expression via MyoD Core Enhancer Transcription.

Scionti I, Hayashi S, Mouradian S, Girard E, Esteves de Lima J, Morel V, Simonet T, Wurmser M, Maire P, Ancelin K, Metzger E, Schüle R, Goillot E, Relaix F, Schaeffer L.

Cell Rep. 2017 Feb 21;18(8):1996-2006. doi: 10.1016/j.celrep.2017.01.078.

5.

Phosphorylation of NBR1 by GSK3 modulates protein aggregation.

Nicot AS, Lo Verso F, Ratti F, Pilot-Storck F, Streichenberger N, Sandri M, Schaeffer L, Goillot E.

Autophagy. 2014 Jun;10(6):1036-53. doi: 10.4161/auto.28479.

6.

A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia.

Ben Ammar A, Soltanzadeh P, Bauché S, Richard P, Goillot E, Herbst R, Gaudon K, Huzé C, Schaeffer L, Yamanashi Y, Higuchi O, Taly A, Koenig J, Leroy JP, Hentati F, Najmabadi H, Kahrizi K, Ilkhani M, Fardeau M, Eymard B, Hantaï D.

PLoS One. 2013;8(1):e53826. doi: 10.1371/journal.pone.0053826. Epub 2013 Jan 9. Erratum in: PLoS One. 2013;8(9). doi: 10.1371/annotation/3ff2b918-c83c-4c6f-a2e2-4d91294ec92f.

7.

CKIP-1 regulates mammalian and zebrafish myoblast fusion.

Baas D, Caussanel-Boude S, Guiraud A, Calhabeu F, Delaune E, Pilot F, Chopin E, Machuca-Gayet I, Vernay A, Bertrand S, Rual JF, Jurdic P, Hill DE, Vidal M, Schaeffer L, Goillot E.

J Cell Sci. 2012 Aug 15;125(Pt 16):3790-800. doi: 10.1242/jcs.101048. Epub 2012 May 2.

8.

Wnt4 participates in the formation of vertebrate neuromuscular junction.

Strochlic L, Falk J, Goillot E, Sigoillot S, Bourgeois F, Delers P, Rouvière J, Swain A, Castellani V, Schaeffer L, Legay C.

PLoS One. 2012;7(1):e29976. doi: 10.1371/journal.pone.0029976. Epub 2012 Jan 12.

9.

Interactome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactor.

Pilot-Storck F, Chopin E, Rual JF, Baudot A, Dobrokhotov P, Robinson-Rechavi M, Brun C, Cusick ME, Hill DE, Schaeffer L, Vidal M, Goillot E.

Mol Cell Proteomics. 2010 Jul;9(7):1578-93. doi: 10.1074/mcp.M900568-MCP200. Epub 2010 Apr 5.

10.

Identification of an agrin mutation that causes congenital myasthenia and affects synapse function.

Huzé C, Bauché S, Richard P, Chevessier F, Goillot E, Gaudon K, Ben Ammar A, Chaboud A, Grosjean I, Lecuyer HA, Bernard V, Rouche A, Alexandri N, Kuntzer T, Fardeau M, Fournier E, Brancaccio A, Rüegg MA, Koenig J, Eymard B, Schaeffer L, Hantaï D.

Am J Hum Genet. 2009 Aug;85(2):155-67. doi: 10.1016/j.ajhg.2009.06.015. Epub 2009 Jul 23. Erratum in: Am J Hum Genet. 2009 Oct;85(4):536.

11.

Evolution of the global internal dynamics of a living cell nucleus during interphase.

Suissa M, Place C, Goillot E, Freyssingeas E.

Biophys J. 2009 Jul 22;97(2):453-61. doi: 10.1016/j.bpj.2009.04.046.

12.

Internal dynamics of a living cell nucleus investigated by dynamic light scattering.

Suissa M, Place C, Goillot E, Freyssingeas E.

Eur Phys J E Soft Matter. 2008 Aug;26(4):435-48. doi: 10.1140/epje/i2007-10346-5.

PMID:
19230214
13.

Towards the molecular elucidation of congenital myasthenic syndromes: identification of mutations in MuSK.

Chevessier F, Faraut B, Ravel-Chapuis A, Richard P, Gaudon K, Bauché S, Prioleau C, Herbst R, Goillot E, Ioos C, Azulay JP, Attarian S, Leroy JP, Fournier E, Legay C, Schaeffer L, Koenig J, Fardeau M, Eymard B, Pouget J, Hantaï D.

Acta Myol. 2005 Oct;24(2):55-9.

PMID:
16550915
14.

[Pathophysiological characterization of congenital myasthenic syndromes: the example of mutations in the MUSK gene].

Chevessier F, Faraut B, Ravel-Chapuis A, Richard P, Gaudon K, Bauché S, Prioleau C, Herbst R, Goillot E, Ioos C, Azulay JP, Attarian S, Leroy JP, Fournier E, Legay C, Schaeffer L, Koenig J, Fardeau M, Eymard B, Pouget J, Hantaï D.

J Soc Biol. 2005;199(1):61-77. French.

PMID:
16114265
15.

MUSK, a new target for mutations causing congenital myasthenic syndrome.

Chevessier F, Faraut B, Ravel-Chapuis A, Richard P, Gaudon K, Bauché S, Prioleau C, Herbst R, Goillot E, Ioos C, Azulay JP, Attarian S, Leroy JP, Fournier E, Legay C, Schaeffer L, Koenig J, Fardeau M, Eymard B, Pouget J, Hantaï D.

Hum Mol Genet. 2004 Dec 15;13(24):3229-40. Epub 2004 Oct 20.

PMID:
15496425
16.

Role for the pleckstrin homology domain-containing protein CKIP-1 in phosphatidylinositol 3-kinase-regulated muscle differentiation.

Safi A, Vandromme M, Caussanel S, Valdacci L, Baas D, Vidal M, Brun G, Schaeffer L, Goillot E.

Mol Cell Biol. 2004 Feb;24(3):1245-55.

17.

Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway.

Goillot E, Raingeaud J, Ranger A, Tepper RI, Davis RJ, Harlow E, Sanchez I.

Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3302-7.

18.

Tumor induction and tissue atrophy in mice lacking E2F-1.

Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ.

Cell. 1996 May 17;85(4):537-48.

19.

IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivo.

Wang L, Goillot E, Tepper RI.

Cell Immunol. 1994 Dec;159(2):152-69.

PMID:
7994751
20.

Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma.

Blay JY, Negrier S, Combaret V, Attali S, Goillot E, Merrouche Y, Mercatello A, Ravault A, Tourani JM, Moskovtchenko JF, et al.

Cancer Res. 1992 Jun 15;52(12):3317-22.

Supplemental Content

Loading ...
Support Center